Extended Release Dosage Forms
Chapter 9: Solid Oral EXTENDED RELEASE Dosage Forms |
|
ADVANTAGE |
Criteria |
Less fluctuation in blood levels |
Not slow or fast absorption/excretion |
Frequency reduction in dosing |
Uniformly absorb GI tract |
Enhanced convenience and compliance |
Good margin of SAFETY |
Reduction of adverse effect |
FOR CHRONIC CONDITIONS |
Reduction in overall cost |
|
TERMS |
|
Modified Release |
Features not offered by conventional forms Based on time course location |
Extended release |
Reduction in dosing frequency |
Delayed release |
Could be enteric coated (gastric pH) Release drug at a time other than promptly after admin |
Repeat Action |
Contain two single dose 1. Immediate release 2. Delayed release
|
Targeted Release |
Directingor isolating drug in body region, tissue or site for absorption or for drug action |
TECHNOLOGY |
|
1. Multitablet |
|
2. Microencapsulation |
S,l,gas, enclosed in microscopic particle |
3. Osmotic PUMP |
OROS system Termed GITS GI therapeutic system Glucotrol XL, Procardia XL
COER (controlled onset ext release) Covera-HS tabs
|
Repeat action tabs |
Repetab |
|
|
|
|
0 comments: